Interleukin-12 Antagonist [EPC]

102257 reported adverse events

Drugs of this class: USTEKINUMAB-TTWE USTEKINUMAB USTEKINUMAB-AAUZ USTEKINUMAB-AEKN USTEKINUMAB-AUUB USTEKINUMAB-HMNY USTEKINUMAB-STBA

These side effects are most commonly reported by patients taking drugs of the Interleukin-12 Antagonist [EPC] class:

#	Side effect	Count
0	DRUG INEFFECTIVE	14813
1	OFF LABEL USE	12734
2	PRODUCT DOSE OMISSION ISSUE	10097
3	FATIGUE	6864
4	PSORIASIS	6590
5	PAIN	6236
6	CROHN^S DISEASE	5912
7	ARTHRALGIA	5839
8	RASH	5635
9	PRODUCT USE ISSUE	5433

See all common reactions for Interleukin-12 Antagonist [EPC]

Drugs of the Interleukin-12 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY	408	0.6191
1	SWOLLEN JOINT COUNT INCREASED	1892	0.6145
2	RHEUMATIC FEVER	2495	0.5786
3	LUPUS VULGARIS	661	0.5626
4	C-REACTIVE PROTEIN	487	0.5435
5	DEEP VEIN THROMBOSIS POSTOPERATIVE	1039	0.5367
6	RHEUMATOID FACTOR POSITIVE	2939	0.5161
7	SWOLLEN JOINT COUNT	125	0.5144
8	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE	3572	0.5092
9	GRIP STRENGTH	114	0.4978

See all enriched reactions for Interleukin-12 Antagonist [EPC]